Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP814912.RA6zh42PgSWhZGJgZmYziJVKa3aEqkUx5xFyVDHH8bdCc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP814912.RA6zh42PgSWhZGJgZmYziJVKa3aEqkUx5xFyVDHH8bdCc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP814912.RA6zh42PgSWhZGJgZmYziJVKa3aEqkUx5xFyVDHH8bdCc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP814912.RA6zh42PgSWhZGJgZmYziJVKa3aEqkUx5xFyVDHH8bdCc130_provenance.
- NP814912.RA6zh42PgSWhZGJgZmYziJVKa3aEqkUx5xFyVDHH8bdCc130_assertion description "[We used the hTERT promoter to drive the expression of the hNIS and human thyroid peroxidase (hTPO) gene as a primary step for testing the effects of radioiodine therapy on malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814912.RA6zh42PgSWhZGJgZmYziJVKa3aEqkUx5xFyVDHH8bdCc130_provenance.
- NP814912.RA6zh42PgSWhZGJgZmYziJVKa3aEqkUx5xFyVDHH8bdCc130_assertion evidence source_evidence_literature NP814912.RA6zh42PgSWhZGJgZmYziJVKa3aEqkUx5xFyVDHH8bdCc130_provenance.
- NP814912.RA6zh42PgSWhZGJgZmYziJVKa3aEqkUx5xFyVDHH8bdCc130_assertion SIO_000772 21801606 NP814912.RA6zh42PgSWhZGJgZmYziJVKa3aEqkUx5xFyVDHH8bdCc130_provenance.
- NP814912.RA6zh42PgSWhZGJgZmYziJVKa3aEqkUx5xFyVDHH8bdCc130_assertion wasDerivedFrom befree-20140225 NP814912.RA6zh42PgSWhZGJgZmYziJVKa3aEqkUx5xFyVDHH8bdCc130_provenance.
- NP814912.RA6zh42PgSWhZGJgZmYziJVKa3aEqkUx5xFyVDHH8bdCc130_assertion wasGeneratedBy ECO_0000203 NP814912.RA6zh42PgSWhZGJgZmYziJVKa3aEqkUx5xFyVDHH8bdCc130_provenance.
- befree-20140225 importedOn "2014-02-25" NP814912.RA6zh42PgSWhZGJgZmYziJVKa3aEqkUx5xFyVDHH8bdCc130_provenance.